Therapies for Children With Autism Spectrum Disorders

89. Allison DB, Basile VC and MacDonald RB. Brief report: comparative effects of
antecedent exercise and lorazepam on the aggressive behavior of an autistic man. J
Autism Dev Disord. 1991 Mar;21(1):89-94. X-1, X-3, X-10
90. Alonim H. The Mifne Method--ISRAEL: Early intervention in the treatment of
autism/PDD: A therapeutic programme for the nuclear family and their child. Journal of
Child and Adolescent Mental Health. 2004;16(1):39-43. X-1, X-2, X-3, X-4
91. Alpern CS and Zager D. Addressing Communication Needs of Young Adults with
Autism in a College-Based Inclusion Program. Education and Training in Developmental
Disabilities. 2007 Dec;42(4):428-436. X-1, X-2, X-3, X-4
92. Al-Shammari Z. Special Education Teachers’ Attitudes toward Autistic Students in the
Autism School in the State of Kuwait: A Case Study. Journal of Instructional
Psychology. 2006 Sep;33(3):170-178. X-1, X-3, X-4
93. Altschuler EL. Play with online virtual pets as a method to improve mirror neuron and
real world functioning in autistic children. Med Hypotheses. 2008;70(4):748-9. X-1, X-2,
X-3, X-4
94. Alvarez A. The problem of neutrality: Some reflections on the psychoanalytic attitude in
the treatment of borderline and psychotic children. Journal of Child Psychotherapy.
1985;11(1):87-103. X-1, X-2, X-3, X-4, X-10
95. Alvarez A. Making the thought thinkable: On introjection and projection. Psychoanalytic
Inquiry. 1993;13(1):103-122. X-1, X-2, X-3, X-4, X-10
96. Alvin J. A research project-Martin. Nordic Journal of Music Therapy. 2000;9(1):50-59.
X-3
97. Aly H. Preemptive strike in the war on pain: is it a safe strategy for our vulnerable
infants? Pediatrics. 2004 Nov;114(5):1335-7. X-1, X-2, X-3, X-4
98. Aman MG. Management of hyperactivity and other acting-out problems in patients with
autism spectrum disorder. Semin Pediatr Neurol. 2004 Sep;11(3):225-8. X-1, X-2, X-3
99. Aman MG and Armstrong SA. Regarding secretin for treating autistic disorder. Journal
of Autism and Developmental Disorders. 2000 Feb;30(1):71-72. X-3
100. Aman MG, De Smedt G, Derivan A, et al. Double-blind, placebo-controlled study of
risperidone for the treatment of disruptive behaviors in children with subaverage
intelligence. Am J Psychiatry. 2002 Aug;159(8):1337-46. X-1, X-3, X-4
101. Aman MG, Lam KS and Collier-Crespin A. Prevalence and patterns of use of
psychoactive medicines among individuals with autism in the Autism Society of Ohio. J
Autism Dev Disord. 2003 Oct;33(5):527-34. X-4
102. Aman MG, Lam KS and Van Bourgondien ME. Medication patterns in patients with
autism: temporal, regional, and demographic influences. J Child Adolesc
Psychopharmacol. 2005 Feb;15(1):116-26. X-4
103. Aman MG and Langworthy KS. Pharmacotherapy for hyperactivity in children with
autism and other pervasive developmental disorders. J Autism Dev Disord. 2000
Oct;30(5):451-9. X-1, X-2, X-3
D-7